WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Becton, Dickinson and Company vs Boston Scientific Corporation

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Becton, Dickinson and Company

BDX · New York Stock Exchange

Market cap (USD)$50.9B
Gross margin (TTM)46.1%
Operating margin (TTM)9.8%
Net margin (TTM)4.5%
SectorHealthcare
IndustryMedical instruments and supplies
CountryUS
Data as of2026-08-23
65/100
Moat score

Partial score covering 71% of segment weight.

Full stock profile

Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.

View BDX analysis

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$71B
Gross margin (TTM)71.2%
Operating margin (TTM)21.5%
Net margin (TTM)17.5%
SectorHealthcare
IndustryMedical devices
CountryUS
Data as of2026-08-23
66/100
Moat score

Partial score covering 86% of segment weight.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Comparison highlights

  • Segment focus: Becton, Dickinson and Company has 4 segments (34.7% in Medical Essentials); Boston Scientific Corporation has 4 segments (66.9% in Cardiovascular).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
  • Moat breadth: Becton, Dickinson and Company has 5 moat types across 2 domains; Boston Scientific Corporation has 3 across 2.

Primary market context

Becton, Dickinson and Company

Medical Essentials

Market

Single-use medical consumables and specimen collection systems

Geography

Global

Customer

Healthcare providers and clinical labs

Role

Manufacturer

Revenue share

34.7%

Boston Scientific Corporation

Cardiovascular

Market

Cardiovascular devices (interventional cardiology, vascular therapies, structural heart, electrophysiology, cardiac rhythm management, remote monitoring, and interventional oncology/embolization)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists, vascular specialists, interventional radiologists/oncologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

66.9%

Side-by-side metrics

Becton, Dickinson and Company
Boston Scientific Corporation
Ticker / Exchange
BDX - New York Stock Exchange
BSX - New York Stock Exchange
Market cap (USD)
$50.9B
$71B
Gross margin (TTM)
46.1%
71.2%
Operating margin (TTM)
9.8%
21.5%
Net margin (TTM)
4.5%
17.5%
Sector
Healthcare
Healthcare
Industry
Medical instruments and supplies
Medical devices
HQ country
US
US
Primary segment
Medical Essentials
Cardiovascular
Market structure
Competitive
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Weak
Moderate
Moat score
65 / 100 (partial, 71% coverage)
66 / 100 (partial, 86% coverage)
Moat domains
Supply, Demand
Demand, Legal
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

Installed Base Consumables

Becton, Dickinson and Company strengths

Operational ExcellenceData Workflow LockinLong Term ContractsDesign In Qualification

Boston Scientific Corporation strengths

Training Org Change CostsRegulated Standards Pipe

Segment mix

Becton, Dickinson and Company segments

Full profile >

Medical Essentials

Competitive

34.7%

Connected Care

Oligopoly

24.5%

BioPharma Systems

Oligopoly

11.9%

Interventional

Competitive

28.9%

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

14.4%

Urology

Competitive

12.5%

Neuromodulation

Oligopoly

6.2%

Cardiovascular

Oligopoly

66.9%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.